Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | HALO |
---|---|---|
09:32 ET | 83157 | 42.89 |
09:34 ET | 2689 | 42.74 |
09:36 ET | 12372 | 42.53 |
09:38 ET | 4962 | 42.2 |
09:39 ET | 4225 | 42.3571 |
09:41 ET | 4234 | 42.3339 |
09:43 ET | 3402 | 42.2723 |
09:45 ET | 12323 | 42.13 |
09:48 ET | 8363 | 42.0856 |
09:50 ET | 10817 | 41.93 |
09:52 ET | 30779 | 41.66 |
09:54 ET | 3129 | 41.8072 |
09:56 ET | 3465 | 41.91 |
09:57 ET | 2274 | 41.94 |
09:59 ET | 4186 | 42.02 |
10:01 ET | 2200 | 41.918 |
10:03 ET | 500 | 42.04 |
10:06 ET | 4288 | 42.0975 |
10:08 ET | 800 | 42.14 |
10:10 ET | 2856 | 42.24 |
10:12 ET | 7703 | 42.25 |
10:14 ET | 4310 | 42.31 |
10:15 ET | 11602 | 42.2 |
10:17 ET | 1597 | 42.16 |
10:19 ET | 4991 | 42.23 |
10:21 ET | 1789 | 42.37 |
10:24 ET | 3030 | 42.31 |
10:26 ET | 2455 | 42.23 |
10:28 ET | 1896 | 42.26 |
10:30 ET | 2241 | 42.3 |
10:32 ET | 2530 | 42.3 |
10:33 ET | 2503 | 42.39 |
10:35 ET | 4531 | 42.4799 |
10:37 ET | 700 | 42.49 |
10:39 ET | 9152 | 42.54 |
10:42 ET | 1561 | 42.34 |
10:44 ET | 3070 | 42.38 |
10:46 ET | 3419 | 42.3319 |
10:48 ET | 2200 | 42.47 |
10:50 ET | 4512 | 42.38 |
10:51 ET | 1495 | 42.305 |
10:53 ET | 1909 | 42.2134 |
10:55 ET | 1710 | 42.185 |
10:57 ET | 5647 | 42.09 |
11:00 ET | 6061 | 42.06 |
11:02 ET | 11595 | 42.08 |
11:04 ET | 2733 | 42.1 |
11:06 ET | 762 | 42.12 |
11:08 ET | 3878 | 42.018 |
11:09 ET | 1409 | 42.07 |
11:11 ET | 4692 | 41.94 |
11:13 ET | 4535 | 41.9845 |
11:15 ET | 1440 | 42.08 |
11:18 ET | 2850 | 42.08 |
11:20 ET | 1483 | 42.17 |
11:22 ET | 3383 | 42.255 |
11:24 ET | 3357 | 42.27 |
11:26 ET | 427 | 42.3195 |
11:27 ET | 9908 | 42.215 |
11:29 ET | 2025 | 42.29 |
11:31 ET | 2700 | 42.32 |
11:33 ET | 635 | 42.34 |
11:36 ET | 705 | 42.385 |
11:38 ET | 2514 | 42.375 |
11:40 ET | 1112 | 42.44 |
11:42 ET | 479 | 42.53 |
11:44 ET | 2699 | 42.5 |
11:45 ET | 900 | 42.52 |
11:47 ET | 1150 | 42.51 |
11:49 ET | 3295 | 42.53 |
11:51 ET | 7580 | 42.5 |
11:54 ET | 16794 | 42.43 |
11:56 ET | 2950 | 42.46 |
11:58 ET | 3278 | 42.4207 |
12:00 ET | 1685 | 42.42 |
12:02 ET | 973 | 42.39 |
12:03 ET | 3522 | 42.4 |
12:05 ET | 1400 | 42.41 |
12:07 ET | 2097 | 42.35 |
12:09 ET | 1256 | 42.335 |
12:12 ET | 2697 | 42.3756 |
12:14 ET | 200 | 42.39 |
12:16 ET | 1302 | 42.42 |
12:18 ET | 300 | 42.435 |
12:20 ET | 2957 | 42.49 |
12:21 ET | 389 | 42.46 |
12:23 ET | 2800 | 42.475 |
12:25 ET | 1663 | 42.53 |
12:27 ET | 600 | 42.55 |
12:30 ET | 6392 | 42.516 |
12:32 ET | 2229 | 42.54 |
12:34 ET | 1851 | 42.46 |
12:36 ET | 939 | 42.52 |
12:38 ET | 200 | 42.54 |
12:39 ET | 500 | 42.63 |
12:41 ET | 3000 | 42.57 |
12:43 ET | 735 | 42.595 |
12:45 ET | 2047 | 42.66 |
12:48 ET | 1103 | 42.64 |
12:50 ET | 1724 | 42.61 |
12:52 ET | 880 | 42.63 |
12:54 ET | 852 | 42.68 |
12:56 ET | 400 | 42.65 |
12:57 ET | 8877 | 42.7 |
12:59 ET | 814 | 42.645 |
01:01 ET | 500 | 42.6636 |
01:03 ET | 1338 | 42.6 |
01:06 ET | 1800 | 42.58 |
01:08 ET | 958 | 42.51 |
01:10 ET | 900 | 42.49 |
01:12 ET | 1700 | 42.47 |
01:14 ET | 485 | 42.47 |
01:15 ET | 1104 | 42.45 |
01:17 ET | 1002 | 42.47 |
01:19 ET | 644 | 42.5 |
01:21 ET | 1000 | 42.52 |
01:24 ET | 1776 | 42.505 |
01:26 ET | 404 | 42.53 |
01:28 ET | 1753 | 42.5 |
01:30 ET | 1698 | 42.41 |
01:32 ET | 1600 | 42.36 |
01:33 ET | 3192 | 42.4062 |
01:35 ET | 1000 | 42.39 |
01:37 ET | 1790 | 42.33 |
01:39 ET | 1500 | 42.4 |
01:42 ET | 1100 | 42.39 |
01:44 ET | 1471 | 42.44 |
01:46 ET | 2000 | 42.36 |
01:48 ET | 1215 | 42.4 |
01:50 ET | 100 | 42.395 |
01:51 ET | 2902 | 42.34 |
01:53 ET | 1100 | 42.34 |
01:55 ET | 3280 | 42.36 |
01:57 ET | 2100 | 42.38 |
02:00 ET | 4807 | 42.4201 |
02:02 ET | 915 | 42.425 |
02:04 ET | 714 | 42.46 |
02:06 ET | 2425 | 42.45 |
02:08 ET | 500 | 42.44 |
02:09 ET | 2665 | 42.43 |
02:11 ET | 1300 | 42.445 |
02:13 ET | 800 | 42.41 |
02:15 ET | 700 | 42.4182 |
02:18 ET | 200 | 42.42 |
02:20 ET | 3208 | 42.39 |
02:22 ET | 1700 | 42.455 |
02:24 ET | 600 | 42.49 |
02:26 ET | 1076 | 42.455 |
02:27 ET | 2401 | 42.425 |
02:29 ET | 1262 | 42.46 |
02:31 ET | 700 | 42.45 |
02:33 ET | 500 | 42.49 |
02:36 ET | 1000 | 42.47 |
02:38 ET | 2200 | 42.4444 |
02:40 ET | 1783 | 42.48 |
02:42 ET | 1720 | 42.475 |
02:44 ET | 6415 | 42.54 |
02:45 ET | 3887 | 42.54 |
02:47 ET | 531 | 42.56 |
02:49 ET | 1195 | 42.57 |
02:51 ET | 3648 | 42.565 |
02:54 ET | 3240 | 42.48 |
02:56 ET | 2827 | 42.46 |
02:58 ET | 1402 | 42.42 |
03:00 ET | 700 | 42.4 |
03:02 ET | 1148 | 42.39 |
03:03 ET | 1502 | 42.33 |
03:05 ET | 300 | 42.31 |
03:07 ET | 4290 | 42.35 |
03:09 ET | 200 | 42.355 |
03:12 ET | 739 | 42.38 |
03:14 ET | 6270 | 42.38 |
03:16 ET | 1916 | 42.39 |
03:18 ET | 3100 | 42.41 |
03:20 ET | 6449 | 42.39 |
03:21 ET | 3966 | 42.385 |
03:23 ET | 1451 | 42.31 |
03:25 ET | 2600 | 42.34 |
03:27 ET | 1730 | 42.28 |
03:30 ET | 6500 | 42.29 |
03:32 ET | 2825 | 42.31 |
03:34 ET | 2600 | 42.34 |
03:36 ET | 4373 | 42.355 |
03:38 ET | 3000 | 42.38 |
03:39 ET | 3430 | 42.36 |
03:41 ET | 3935 | 42.42 |
03:43 ET | 5209 | 42.4208 |
03:45 ET | 5204 | 42.51 |
03:48 ET | 3450 | 42.42 |
03:50 ET | 3113 | 42.41 |
03:52 ET | 4880 | 42.48 |
03:54 ET | 4673 | 42.41 |
03:56 ET | 11229 | 42.36 |
03:57 ET | 14454 | 42.35 |
03:59 ET | 41373 | 42.26 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Halozyme Therapeutics Inc | 6.1B | 16.7x | --- |
Guardant Health Inc | 5.4B | -8.8x | --- |
Azenta Inc | 4.6B | -151.1x | --- |
Ionis Pharmaceuticals Inc | 6.5B | -225.3x | --- |
Cerevel Therapeutics Holdings Inc | 6.2B | -17.2x | --- |
Maravai LifeSciences Holdings Inc | 6.7B | 12.8x | --- |
Halozyme Therapeutics, Inc. is a biopharma technology platform company. The Company licenses its technology to biopharmaceutical companies to collaboratively develop products that combine its ENHANZE drug delivery technology with the collaborators' compounds. The Company's lead enzyme, rHuPH20, is used to facilitate the delivery of injected drugs and fluids. The Company's approved product and its collaborators’ approved products and product candidates are based on rHuPH20, a patented recombinant human hyaluronidase enzyme. The Company's lead product, Hylenex recombinant, is a formulation of rHuPH20 that facilitates subcutaneous fluid administration for achieving hydration, to increase the dispersion and absorption of other injected drugs and, in subcutaneous urography, to improve resorption of radiopaque agents. The rHuPH20 can be applied as a drug delivery platform to increase dispersion and absorption of other injected drugs and fluids, potentially reducing the treatment burden.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.1B |
---|---|
Revenue (TTM) | $487.5M |
Shares Outstanding | 137.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.19 |
EPS | $2.52 |
Book Value | $1.43 |
P/E Ratio | 16.7x |
Price/Sales (TTM) | 12.5 |
Price/Cash Flow (TTM) | 16.0x |
Operating Margin | 49.61% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.